Eyebright Medical announced that shareholder Bai Ying, due to personal funding needs, will reduce holdings by a total of 3.8627 million shares through block trading from July 22, 2025, to September 3, 2025, accounting for 1.9972% of the company's current total share capital; the combined shareholding ratio of Bai Ying and concerted actor Mao Liping has decreased from 7.85% to 5.85%, and the reduction plan has been fully implemented